ea0099p345 | Pituitary and Neuroendocrinology | ECE2024
Hebb Andrea
, Croul Sidney
, Han Jae
, Massoud Emad
, Tramble Lisa
, Imran Syed
, Clarke David
Introduction: While there is a significant risk of recurrence in nonfunctioning pituitary adenoma (NFPA) after surgery, it is challenging to predict which NFPAs will recur based solely on routine histopathology. To better understand markers of recurrence, we assessed the established tumor markers linked to aggressive tumor behavior including X-linked IAP (XIAP), the most potent inhibitor of the apoptosis protein family, vascular epithelial growth factor (VEGF) which facilitate...